Health
Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co. – News-Medical.net
Horizon Discovery today announced that it has granted commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou will use Horizon’s gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster…
-
Noosa News23 hours agoRedland City Council questions school’s koala habitat assessment for sports facility expansion
-
General23 hours agoAHPRA puts practice conditions on neurosurgeon Greg Malham
-
Noosa News22 hours agoWhat’s the happiest country in the world? Take the Brisbane Times Quiz
-
Noosa News22 hours agoHidden wetlands help cattle and conservation coexist as farmers race towards climate adaptation